Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Doreen Brettler MD

    TitleProfessor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentMedicine
    AddressUniversity of Massachusetts Medical School
    55 Lake Avenue North
    Worcester MA 01655
    Phone508-334-6093
        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Tipirneni E, Buttar A, Brettler D, Miron P, Bathini V. Chronic myeloproliferative disorder with ETV6-PDGFRß fusion gene. Ann Hematol. 2012 Apr; 91(4):637-8.
          View in: PubMed
        2. Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol. 2009 Aug; 40(8):1194-9.
          View in: PubMed
        3. Cerny J, Wang S, Miron P, Hutchinson L, Brettler D. EBV-negative Hodgkin lymphoma in ZAP-70-positive B-cell lymphocytic leukemia patient. Ann Hematol. 2009 May; 88(5):495-7.
          View in: PubMed
        4. Brettler DB. Gene therapy for hemophilia? J Thromb Haemost. 2005 Jun; 3(6):1317-9.
          View in: PubMed
        5. Engelfriet CP, Reesink HW, Mannucci PM, Gringeri A, Ingerslev J, Brettler DB, Mauser-Bunschoten EP, Negrier C, Berntorp E, Smith OP, Shapiro AD. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies. Vox Sang. 2000; 78(4):256-61.
          View in: PubMed
        6. Greenough TC, Brettler DB, Kirchhoff F, Alexander L, Desrosiers RC, O'Brien SJ, Somasundaran M, Luzuriaga K, Sullivan JL. Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort. J Infect Dis. 1999 Dec; 180(6):1790-802.
          View in: PubMed
        7. Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis. 1997 Jul; 176(1):118-25.
          View in: PubMed
        8. Brettler DB. A recombinant circumsporozoite protein vaccine against malaria. N Engl J Med. 1997 Jun 12; 336(24):1759; author reply 1760-1.
          View in: PubMed
        9. Ragni MV, Belle SH, Jaffe R, Locker J, Duerstein SL, Bass DC, Addiego JE, Aledort LM, Barron LE, Brettler DB, Buchanan GR, Gill JC, Ewenstein BM, Green D, Hilgartner MW, Hoots WK, Kisker CT, Lovrien EW, Rutherford CJ, Sanders NL, Smith KJ, Stabler SP, Swindells S, White GC, Kingsley LA. AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in hemophiliacs. Hemophilia Malignancy Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep; 13(1):78-86.
          View in: PubMed
        10. Shopnick RI, Brettler DB. Hemostasis: a practical review of conservative and operative care. Clin Orthop Relat Res. 1996 Jul; (328):34-8.
          View in: PubMed
        11. Brettler DB. Inhibitors in congenital haemophilia. Baillieres Clin Haematol. 1996 Jun; 9(2):319-29.
          View in: PubMed
        12. Shopnick RI, Kazemi M, Brettler DB, Buckwalter C, Yang L, Bray G, Gomperts ED. Anaphylaxis after treatment with recombinant factor VIII. Transfusion. 1996 Apr; 36(4):358-61.
          View in: PubMed
        13. Shopnick RI, Brettler DB, Bolivar E. Hepatitis C virus transmission by monoclonal purified viral-attenuated factor VIII concentrate. Lancet. 1995 Sep 2; 346(8975):645.
          View in: PubMed
        14. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995 Jan 26; 332(4):228-32.
          View in: PubMed
        15. Greenough TC, Somasundaran M, Brettler DB, Hesselton RM, Alimenti A, Kirchhoff F, Panicali D, Sullivan JL. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses. 1994 Apr; 10(4):395-403.
          View in: PubMed
        16. Mannucci PM, Brettler DB, Aledort LM, Lusher JM, Abildgaard CF, Schwartz RS, Hurst D. Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group. Blood. 1994 Apr 1; 83(7):1958-62.
          View in: PubMed
        17. Brettler DB. Inhibitors of factor VIII: detection and treatment. Southeast Asian J Trop Med Public Health. 1993; 24 Suppl 1:21-5.
          View in: PubMed
        18. Brettler DB. Comprehensive hemophilia care and home factor infusions. Southeast Asian J Trop Med Public Health. 1993; 24 Suppl 1:41-2.
          View in: PubMed
        19. Brettler DB, Somasundaran M, Forsberg AF, Krause E, Sullivan JL. Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population. Blood. 1992 Nov 1; 80(9):2396-400.
          View in: PubMed
        20. Brettler DB, Mannucci PM, Gringeri A, Rasko JE, Forsberg AD, Rumi MG, Garsia RJ, Rickard KA, Colombo M. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood. 1992 Jul 15; 80(2):540-3.
          View in: PubMed
        21. Bauer KA, Mannucci PM, Gringeri A, Tradati F, Barzegar S, Kass BL, ten Cate H, Kestin AS, Brettler DB, Rosenberg RD. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo. Blood. 1992 Apr 15; 79(8):2039-47.
          View in: PubMed
        22. Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PB, Kunschak M, McMillan CW, et al. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group. Transfusion. 1992 Feb; 32(2):134-8.
          View in: PubMed
        23. Kasper CK, Mannucci PM, Bulyzhenkov V, Brettler DB, Chuansumrit A, Heijnen L, Isarankura P, Kernoff PB, Peake I, Rickard KA, et al. Hemophilia in the 1990s: principles of management and improved access to care. Semin Thromb Hemost. 1992 Jan; 18(1):1-10.
          View in: PubMed
        24. Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med. 1991 Dec 1; 174(6):1593-600.
          View in: PubMed
        25. Kraus EM, Brettler DB, Forsberg AD, Sullivan JL. Pregnancy in a cohort of long-term partners of human immunodeficiency virus-seropositive hemophiliacs. Obstet Gynecol. 1991 Nov; 78(5 Pt 1):735-8.
          View in: PubMed
        26. Colombo M, Mannucci PM, Brettler DB, Girolami A, Lian EC, Rodeghiero F, Scharrer I, Smith PS, White GC. Hepatocellular carcinoma in hemophilia. Am J Hematol. 1991 Aug; 37(4):243-6.
          View in: PubMed
        27. Luzuriaga K, Koup RA, Pikora CA, Brettler DB, Sullivan JL. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J Pediatr. 1991 Aug; 119(2):230-6.
          View in: PubMed
        28. Brettler DB. Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates. Semin Hematol. 1991 Apr; 28(2 Suppl 1):45-6.
          View in: PubMed
        29. Kasper CK, Mannucci PM, Bulyzhenkov V, Brettler DB, Chuansumrit A, Heijnen L, Isarankura P, Kernoff PB, Peake I, Rickard KA, et al. Haemophilia in the 1990s: report of a joint meeting of the World Health Organization and World Federation of Hemophilia. Vox Sang. 1991; 61(3):221-4.
          View in: PubMed
        30. Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, et al. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med. 1990 Dec 27; 323(26):1800-5.
          View in: PubMed
        31. Brettler DB, Forsberg A, Bolivar E, Brewster F, Sullivan J. Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia. J Pediatr. 1990 Oct; 117(4):584-8.
          View in: PubMed
        32. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood. 1990 Jul 1; 76(1):254-6.
          View in: PubMed
        33. Mannucci PM, Schimpf K, Brettler DB, Ciavarella N, Colombo M, Haschke F, Lechner K, Lusher J, Weissbach G. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med. 1990 Jul 1; 113(1):27-32.
          View in: PubMed
        34. Brettler DB. Proposed protocol for the evaluation of the effect of high purity factor concentrates on the immune system of hemophilia patients. Thromb Haemost. 1989 Sep 29; 62(2):811-2.
          View in: PubMed
        35. Brettler DB, Levine PH. Factor concentrates for treatment of hemophilia: which one to choose? Blood. 1989 Jun; 73(8):2067-73.
          View in: PubMed
        36. Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Arch Intern Med. 1989 Jun; 149(6):1381-5.
          View in: PubMed
        37. Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies. Blood. 1989 May 15; 73(7):1859-63.
          View in: PubMed
        38. Kraus EM, Brettler DB. Assessment of reproductive risks and intentions by mothers of children with hemophilia. Am J Med Genet. 1988 Oct; 31(2):259-67.
          View in: PubMed
        39. Goldsmith GH, Baily RG, Brettler DB, Davidson WR, Ballard JO, Driscol TE, Greenberg JM, Kasper CK, Levine PH, Ratnoff OD. Primary pulmonary hypertension in patients with classic hemophilia. Ann Intern Med. 1988 Jun; 108(6):797-9.
          View in: PubMed
        40. Brettler DB, Forsberg AD, Levine PH, Andrews CA, Baker S, Sullivan JL. Human immunodeficiency virus isolation studies and antibody testing. Household contacts and sexual partners of persons with hemophilia. Arch Intern Med. 1988 Jun; 148(6):1299-301.
          View in: PubMed
        41. Andrews CA, Sullivan JL, Brettler DB, Brewster FE, Forsberg AD, Scesney S, Levine PH. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. J Pediatr. 1987 Nov; 111(5):672-7.
          View in: PubMed
        42. Brettler DB, Brewster F, Levine PH, Forsberg A, Baker S, Sullivan JL. Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B. Blood. 1987 Jul; 70(1):276-81.
          View in: PubMed
        43. Brettler DB, Forsberg AD, Brewster F, Sullivan JL, Levine PH. Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate. Am J Med. 1986 Oct; 81(4):607-11.
          View in: PubMed
        44. Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr. 1986 Apr; 108(4):504-10.
          View in: PubMed
        45. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985 Mar-Apr; 5(2):188-91.
          View in: PubMed
        46. Levine PH, Brettler DB, Sullivan JL. Hemophilia and acquired immune deficiency syndrome. Prog Clin Biol Res. 1985; 182:287-96.
          View in: PubMed
        47. Brettler DB, Forsberg AD, O'Connell FD, Cederbaum AI, Chaitman AK, Levine PH. A long-term study of hemophilic arthropathy of the knee joint on a program of Factor VIII replacement given at time of each hemarthrosis. Am J Hematol. 1985 Jan; 18(1):13-8.
          View in: PubMed
        48. Kitchen LW, Barin F, Sullivan JL, McLane MF, Brettler DB, Levine PH, Essex M. Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature. 1984 Nov 22-28; 312(5992):367-9.
          View in: PubMed
        49. Cheeseman SH, Sullivan JL, Brettler DB, Levine PH. Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndrome. JAMA. 1984 Jul 6; 252(1):83-5.
          View in: PubMed
        50. Tauber AI, Brettler DB, Kennington EA, Blumberg PM. Relation of human neutrophil phorbol ester receptor occupancy and NADPH-oxidase activity. Blood. 1982 Aug; 60(2):333-9.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Doreen's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572